Across TCGA pan-cancer cohorts, CSPP1 mass-spec protein is linked to patient survival in 2 of 34 cancer types, making it a survival-associated CSPP1 data layer compared with 25 for mass-spec protein and 7 for mutation status.
The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher CSPP1 mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated CSPP1 expression acts as an unfavorable survival marker, although some lineages such as UCEC and CCRCC show a favorable association.
UCEC and CCRCC are the cancer types where CSPP1 mass-spec protein most reproducibly stratifies survival.